Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
IASLC WCLC 2026
2026 ASCO GI
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
ELCC 2018 European Lung Cancer Congress
«
1
»
Advertisement
Advertisement
Sep
10
Today In Oncology
FDA Approves Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
FDA Approves Rusfertide for Erythrocytosis in Adults With Polycythemia Vera
FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma
FDA Approves CELMoD Combination Regimen for Pretreated Multiple Myeloma
NSCLC FDA Grants Accelerated Approval to Sevabertinib for Locally Advanced or Metastatic Nonsquamous Disease
View More
Advertisement
